Insmed
INSM
#741
Rank
A$47.47 B
Marketcap
A$222.58
Share price
1.22%
Change (1 day)
75.60%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -A$1.71 Billion

According to Insmed's latest financial reports the company's current earnings are A$0.44 Billion. In 2024 the company made an earning of -A$1.19 Billion a decrease over its 2023 earnings that were of -A$0.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$1.71 Billion44.22%
2024 -A$1.19 Billion23.71%
2023 -A$0.96 Billion45.77%
2022 -A$0.66 Billion15.83%
2021 -A$0.57 Billion50.19%
2020 -A$0.38 Billion16.4%
2019 -A$0.33 Billion-23.9%
2018 -A$0.43 Billion59.35%
2017 -A$0.27 Billion8.52%
2016 -A$0.25 Billion47.25%
2015 -A$0.17 Billion34.53%
2014 -A$0.13 Billion58.83%
2013 -A$78.38 Million35.14%
2012 -A$58 Million-31.92%
2011 -A$85.2 Million854.92%
2010 -A$8.93 Million-105.22%
2009 A$0.17 B-905.06%
2008 -A$21.22 Million-27.31%
2007 -A$29.19 Million-62.41%
2006 -A$77.65 Million98.19%
2005 -A$39.18 Million0.03%
2004 -A$39.17 Million159.07%
2003 -A$15.12 Million-69.31%
2002 -A$49.26 Million
2000 -A$44.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$23.44 B-1,591.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$14.11 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.37 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.37 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$33.2 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$6.29 M-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA